About GenePlanet
GenePlanet is a company based in Ljubljana (Slovenia) founded in 2008 by Nina Sterk and Marko Bitenc. GenePlanet has raised $34.02 million across 3 funding rounds from investors including BlackPeak Capital, JF Investments and Lauxera Capital Partners.
- Headquarter Ljubljana, Slovenia
- Founders Nina Sterk, Marko Bitenc
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website geneplanet.com
- Social LinkedIn Facebook
- Legal Name Geneplanet D.O.O.
- Annual Revenue$5.18 M (USD)49as on Dec 31, 2021
- Net Profit$73.46 K (USD)320as on Dec 31, 2021
- Total Equity Funding$34.02M (USD)
in 3 rounds
- InvestorsBlackPeak Capital
& 2 more
Funding Insights of GenePlanet
GenePlanet has successfully raised a total of $34.02M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.02M
- Total Rounds 3
- First Round $11.74M
(Jul 2018)
- Investors Count 3
All 3 funding rounds of GenePlanet with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2026 | – | Series B | – | – | |
| Jul 2023 | $22.27M | Series B | – | BlackPeak Capital | – |
| Jul 2018 | $11.74M | Series A | – | JF Investments | – |
3 investors in total: 3 institutional.
Investors in GenePlanet
GenePlanet has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include BlackPeak Capital, JF Investments and Lauxera Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in multiple sectors are managed by BlackPeak Capital. | – | blackpeak-capital.com | Sofia, Bulgaria | |
- | – | jfinvestments.tcc.mode | - | |
- | – | lauxera.com | - |
Investor details for GenePlanet
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GenePlanet
30 people are tracked at GenePlanet (13 in leadership, 17 in team).
| Name | Role | Group |
|---|---|---|
Nina Sterk | Co-Founder & Director Of Finance And Accounting | Leadership |
Marko Bitenc | Co-Founder & CEO | Leadership |
Janko Mandić | Head of UX/UI Design and Consultant | Leadership |
Matjaž Petrovič | VP of Sales | Leadership |
Sasha Makarenko | Chief Sales Officer (CSO) | Leadership |
Eva Melanšek | Head of Customer Support | Leadership |
Filip Janžekovič | Head Of Operations | Leadership |
Igor Marjanovic, PhD | Chief Data Officer | Leadership |
Matjaž Stanonik | Head of R&D | Leadership |
Lovro Vidmar | Head of product development - genetics | Leadership |
Andrej Krasevec | Head of Quality | Leadership |
Boris Gorišek | Sales Director | Leadership |
Jacek Konieczny | Head of Sales Poland | Leadership |
Adelina Stefan | National Key Account Manager | Team |
Albin Verčko | Software Engineer | Team |
Matjaž Košir | Coordinator of Logistics and Operation Process | Team |
Leszek Żelazowski | District Sales Manager | Team |
Diana Acosta | Objetivo: Sales profesional extensive in the Pharmacutical industry with an evolutionary visión of | Team |
Suzana Dević | Customer Support Specialist | Team |
Kristina Cerovec | Laboratory and operations assistant | Team |
10 more people are available in the full profile.
Complete people profiles for GenePlanet
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GenePlanet
3 dated milestones of GenePlanet across 18 years, from founding to its latest funding, stage changes and deals.
- Founded GenePlanet is founded.
- Funding First funding round of $11.7M.
- Funding Latest funding round, Series B,.
Web traffic of GenePlanet
The website of GenePlanet (geneplanet.com) receives about 54.7K visits a month.
- Monthly visits54.7K
▼ 22% vs previous month
Websites whose visitors overlap most with GenePlanet. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cdc.gov | 100% | 16.4M | #4,309 | View details | |
| tellmegen.com | 83% | 226.1K | #153,509 | View details | |
| anylabtestnow.com | 82% | 226.2K | #165,753 | View details | |
scopeblog.stanford.edu | scopeblog.stanford.edu | 81% | – | – | – |
genetico.pl | genetico.pl | 77% | – | #2,807,968 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for GenePlanet
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Geneplanet
Complete news archive for GenePlanet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to GenePlanet
10 companies that operate in the same segment as GenePlanet (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GenePlanet
GenePlanet was founded in 2008 and raised its 1st funding round 10 years after it was founded.
GenePlanet is headquartered in Ljubljana, Slovenia.
Marko Bitenc is the current CEO of GenePlanet. They have also founded this company.
GenePlanet is a funded company, having raised a total of $34.02M across 3 funding rounds to date. The company's 1st funding round was a Series A of $11.74M, raised on Jul 2018.
Annual revenue of GenePlanet is $5.18M as on Dec 31, 2021.
GenePlanet was established in 2008 in Ljubljana, Slovenia, within the genetics and health sector. DNA testing kits are supplied to users, who submit saliva samples for laboratory analysis. Customized plans for nutrition, activity, and lifestyle are developed from the genetic data to support early disease prevention. Operations focus on personalized genetic insights for health management.
GenePlanet has 3 investors. Key investors include BlackPeak Capital, JF Investments, and Lauxera Capital Partners.
GenePlanet operates through Geneplanet D.O.O..